Expression of HIV1 and HIV2 polypeptides and their use
US5310876A · kind A · utility
6Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 1991 |
| Grant date | May 10, 1994 |
| Priority date | — |
| Expiry date | Jan 25, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16222
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A fusion protein with at least one antigenic and/or immunogenic determinant from the env, gag and/or pol region of HIV1 and/or HIV2 which contains the tetrapeptide sequence NH.sub.2 -Met-Tyr-Tyr-Leu as the N-terminal component as well as a process for its production and use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.